1 / 19

A More Efficient and Effective Testing and Assessment Paradigm for Chemical Risk Management

A More Efficient and Effective Testing and Assessment Paradigm for Chemical Risk Management. Edward O denkirchen , Ph.D. Office of Pesticide Programs US Environmental Protection Agency. Business Case: Pesticide Risk Management. Mission Statement –

serge
Download Presentation

A More Efficient and Effective Testing and Assessment Paradigm for Chemical Risk Management

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A More Efficient and Effective Testing and Assessment Paradigm for Chemical Risk Management Edward Odenkirchen, Ph.D. Office of Pesticide Programs US Environmental Protection Agency

  2. Business Case: Pesticide Risk Management Mission Statement – • Best possible regulatory decisions to protect public health and environment. • Rely on all best available scientific information. • External Peer-Review; Public Participation. Goal – Timely & targeted credible information to inform decisions. Time & Cost Benefit • Benefits: • Resource Savings • Efficiency • Increase Reliability • Public Trust

  3. Challenges for Risk Assessment Risk Management Tools Risk Assessment Capability & Capacity Scientific & Technological Advancement

  4. Common Risk Management Needs Ecological & Human Health Risk Assessment • Transparency & trust in decision-making. • Resource demands: Effectiveness and efficiency. • Spatial, temporal & biological decision scales. • Integration of multiple stressors: Chemical and Non-Chemical.

  5. 2009 NRC Science & Decisions The committee encourages EPA to focus greater attention on design in the formative stages of risk assessment, specifically on planning and scoping and problem formulation, as articulated in EPA guidance for ecologic and cumulative risk assessment (EPA 1998, 2003).

  6. Characterization of Exposure Characterization of Ecological Effects Communicating Results to the Risk Manager Risk Management Ecological Risk Assessment Planning (Risk Assessor/ Risk Manager Dialogue) PROBLEM FORMULATION A N A L Y S I S RISK CHARACTERIZATION

  7. PROBLEM FORMULATION ANALYSIS RISK CHARACTERIZATION PROBLEM FORMULATION Integrate Available Information Source and Exposure Characteristics Ecosystem Potentially at Risk Ecological Effects Planning (Risk Assessor/ Risk Manager Dialogue) As Necessary: Acquire Data, Iterate Process, Monitor Results Assessment Endpoints Conceptual Model Analysis Plan ANALYSIS

  8. 2007 NRC Toxicity Testing in 21st Century: A Vision and Strategy

  9. NRC 2007 “Toxicity Testing in the 21st Century: A Vision & Strategy” Objective: Foster transformative paradigm shift based largely on increased use of in vitro andin silicosystems that will: Broaden coverage of chemicals, endpoints, life stages. Reduce cost and time of testing, increase efficiency and flexibility. Use fewer animals. Provide more robust data using mode of action and dosimetry information.

  10. Enhanced Integrated Approaches to Testing and Assessment Combine existing exposure and toxicity data including information from new technologies (in silico, in vitro and –omics) to: • Formulate hypotheses about the toxicity potential of a chemical or a chemical category. • Target further data needs specific to a chemical or members of a chemical category for a given exposure. Progressive, Tiered-Evaluation Approach: “Integrate, Formulate, Target”

  11. Adverse Outcome Pathways – definition and example Paradigm Shift in Toxicology: Pathway-based assessment to predict adversity. Exposure Uptake-Delivery to Target Tissues Perturbation “Normal” Biological Function Biologic inputs Cell injury, Inability to regulate Adverse Outcomes (e.g., Mortality, Reproductive Impairment) Chemical Chemical Extrapolation Cellular response pathway Early cellular changes Adaptive Responses Species Extrapolation Adverse outcome relevant to risk assessment Molecular initiating event Perturbed cellular response pathway Chemical & Non- Chemical Stressors Modified From NRC 2007

  12. Spatial, Temporal and Biological Scales Integration of Scales: Source to Outcome

  13. Watersheds with Drinking Water Intakes

  14. In vivo studies Structure Activity Relationships In vitro studies Communities within landscapes Molecular Target Cellular Response Chemicals Pharmaco- kinetics Tissue Organ Population Individual Monitoring Adverse Outcome Pathway Toxicity Pathways Molecular initiating event Key events or predictive relationships spanning levels of biological organization Adverse outcome relevant to risk assessment Greater Toxicological Understanding Greater Risk Relevance

  15. NAS Review of Ecological Risk Assessments Under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and the Endangered Species Act (ESA) Examining scientific and technical issues related to methods and assumptions used by EPA, FWS, and NOAA to carry out joint responsibilities under the ESA and FIFRA.

  16. NAS Review of Ecological Risk Assessments Under FIFRA and ESA Charge Questions - Topic Areas: • Best Available Scientific Data & Information • Geospatial Information and Datasets • Mixtures • Sub-lethal, Indirect, and Cumulative Effects • Models • Interpretation of Uncertainty

  17. Habitat-Species Response Habitat/Biota Distribution Data Layers Demographic Data Life History Data Spatial Models Population Models Chemical Data Layers Species Physiology Data Chemical, Species Dose-Response Data & Models Building Capacity for Explicit Risk Assessments OUTCOME: Efficient-effective site-specific risk assessment

  18. Moving Forward – “Back to the Future” • The technology may be “new”, but the logic for advancing the science to change risk assessment and risk management is not. OECD Principles for QSAR Validation:Transparency & Utility for a Specified Application • Predicted endpoint is defined. • Mechanistic interpretation associated with predictions, if possible. • Defined chemical domain of applicability for the model. • Appropriate measures of goodness of fit, robustness, ability to predict. • An unambiguous algorithm.

  19. Challenges to Accelerate Risk Assessment in the 21st Century Overall objectives are monumental. • Incremental steps; identify opportunities for success; focus on tangible applications (categories, read across, priority setting). Building libraries of information will take time. • Effective use of information technology can help accelerate AOP discovery, development, and evaluation. Establishing linkages depicted in AOPs. • Support transition from qualitative to quantitative uses; species and chemical extrapolations. Establishing linkages across toxicology (human health and ecology). • Multi-talented individuals and teams. Continuum of learning and refining.

More Related